Report Content
Chapter 1 Methodology
1.1 Market definitions
1.2 Base estimates & working
1.2.1 North America
1.2.2 Europe
1.2.3 Asia Pacific
1.2.4 Latin America
1.2.5 Middle East & Africa
1.3 Forecast parameters
1.4 Data validation
1.5 Data Sources
1.5.1 Secondary
1.5.1.1 Paid sources
1.5.1.2 Unpaid sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 Lacrimal devices industry 360° synopsis, 2017 - 2028
2.1.1 Business trends
2.1.2 Product trends
2.1.3 Application trends
2.1.4 End-use trends
2.1.5 Regional trends
Chapter 3 Lacrimal Devices Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2017 - 2028
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Growing prevalence of eye disease
3.3.1.2 Ease of lacrimal treatment procedures
3.3.1.3 Technological advancements in lacrimal devices
3.3.2 Industry pitfalls & challenges
3.3.2.1 High risk of side effects
3.4 Growth potential analysis
3.4.1 By product
3.4.2 By application
3.4.3 By end-use
3.5 COVID-19 impact analysis
3.6 Porter’s analysis
3.7 Competitive landscape
3.7.1 Company matrix analysis, 2021
3.8 PESTEL analysis
Chapter 4 Lacrimal Devices Market, By Product
4.1 Key segment trends
4.2 Intubation sets
4.2.1 Market size, by region, 2017 - 2028 (USD Million)
4.3 Tubes
4.3.1 Market size, by region, 2017 - 2028 (USD Million)
4.4 Stents
4.4.1 Market size, by region, 2017 - 2028 (USD Million)
4.5 Cannula & Spatula
4.5.1 Market size, by region, 2017 - 2028 (USD Million)
4.6 Dilator
4.6.1 Market size, by region, 2017 - 2028 (USD Million)
4.7 Punctal plugs
4.7.1 Market size, by region, 2017 - 2028 (USD Million)
4.8 Others
4.8.1 Market size, by region, 2017 - 2028 (USD Million)
Chapter 5 Lacrimal Devices Market, By Application
5.1 Key segment trends
5.2 Dry eye
5.2.1 Market size, by region, 2017 - 2028 (USD Million)
5.3 Epiphora
5.3.1 Market size, by region, 2017 - 2028 (USD Million)
5.4 Glaucoma
5.4.1 Market size, by region, 2017 - 2028 (USD Million)
5.5 Drainage obstruction
5.5.1 Market size, by region, 2017 - 2028 (USD Million)
5.6 Lacrimal gland inflammation
5.6.1 Market size, by region, 2017 - 2028 (USD Million)
5.7 Others
5.7.1 Market size, by region, 2017 - 2028 (USD Million)
Chapter 6 Lacrimal Devices Market, By End-use
6.1 Key segment trends
6.2 Hospitals
6.2.1 Market size, by region, 2017 - 2028 (USD Million)
6.3 Ophthalmic clinics
6.3.1 Market size, by region, 2017 - 2028 (USD Million)
6.4 Diagnostic centers
6.4.1 Market size, by region, 2017 - 2028 (USD Million)
6.5 Others
6.5.1 Market size, by region, 2017 - 2028 (USD Million)
Chapter 7 Lacrimal Market, By Region
7.1 Key regional trends
7.2 North America
7.2.1 Market size, by country, 2017 - 2028 (USD Million)
7.2.2 Market size, by product, 2017 - 2028 (USD Million)
7.2.3 Market size, by application, 2017 - 2028 (USD Million)
7.2.4 Market size, by end-use, 2017 - 2028 (USD Million)
7.2.5 U.S.
7.2.5.1 Market size, by product, 2017 - 2028 (USD Million)
7.2.5.2 Market size, by application, 2017 - 2028 (USD Million)
7.2.5.3 Market size, by end-use, 2017 - 2028 (USD Million)
7.2.6 Canada
7.2.6.1 Market size, by product, 2017 - 2028 (USD Million)
7.2.6.2 Market size, by application, 2017 - 2028 (USD Million)
7.2.6.3 Market size, by end-use, 2017 - 2028 (USD Million)
7.3 Europe
7.3.1 Market size, by country, 2017 - 2028 (USD Million)
7.3.2 Market size, by product, 2017 - 2028 (USD Million)
7.3.3 Market size, by application, 2017 - 2028 (USD Million)
7.3.4 Market size, by end-use, 2017 - 2028 (USD Million)
7.3.5 Germany
7.3.5.1 Market size, by product, 2017 - 2028 (USD Million)
7.3.5.2 Market size, by application, 2017 - 2028 (USD Million)
7.3.5.3 Market size, by end-use, 2017 - 2028 (USD Million)
7.3.6 UK
7.3.6.1 Market size, by product, 2017 - 2028 (USD Million)
7.3.6.2 Market size, by application, 2017 - 2028 (USD Million)
7.3.6.3 Market size, by end-use, 2017 - 2028 (USD Million)
7.3.7 France
7.3.7.1 Market size, by product, 2017 - 2028 (USD Million)
7.3.7.2 Market size, by application, 2017 - 2028 (USD Million)
7.3.7.3 Market size, by end-use, 2017 - 2028 (USD Million)
7.3.8 Italy
7.3.8.1 Market size, by product, 2017 - 2028 (USD Million)
7.3.8.2 Market size, by application, 2017 - 2028 (USD Million)
7.3.8.3 Market size, by end-use, 2017 - 2028 (USD Million)
7.3.9 Spain
7.3.9.1 Market size, by product, 2017 - 2028 (USD Million)
7.3.9.2 Market size, by application, 2017 - 2028 (USD Million)
7.3.9.3 Market size, by end-use, 2017 - 2028 (USD Million)
7.3.10 Russia
7.3.10.1 Market size, by product, 2017 - 2028 (USD Million)
7.3.10.2 Market size, by application, 2017 - 2028 (USD Million)
7.3.10.3 Market size, by end-use, 2017 - 2028 (USD Million)
7.4 Asia Pacific
7.4.1 Market size, by country, 2017 - 2028 (USD Million)
7.4.2 Market size, by product, 2017 - 2028 (USD Million)
7.4.3 Market size, by application, 2017 - 2028 (USD Million)
7.4.4 Market size, by end-use, 2017 - 2028 (USD Million)
7.4.5 Japan
7.4.5.1 Market size, by product, 2017 - 2028 (USD Million)
7.4.5.2 Market size, by application, 2017 - 2028 (USD Million)
7.4.5.3 Market size, by end-use, 2017 - 2028 (USD Million)
7.4.6 China
7.4.6.1 Market size, by product, 2017 - 2028 (USD Million)
7.4.6.2 Market size, by application, 2017 - 2028 (USD Million)
7.4.6.3 Market size, by end-use, 2017 - 2028 (USD Million)
7.4.7 India
7.4.7.1 Market size, by product, 2017 - 2028 (USD Million)
7.4.7.2 Market size, by application, 2017 - 2028 (USD Million)
7.4.7.3 Market size, by end-use, 2017 - 2028 (USD Million)
7.4.8 Australia
7.4.8.1 Market size, by product, 2017 - 2028 (USD Million)
7.4.8.2 Market size, by application, 2017 - 2028 (USD Million)
7.4.8.3 Market size, by end-use, 2017 - 2028 (USD Million)
7.4.9 South Korea
7.4.9.1 Market size, by product, 2017 - 2028 (USD Million)
7.4.9.2 Market size, by application, 2017 - 2028 (USD Million)
7.4.9.3 Market size, by end-use, 2017 - 2028 (USD Million)
7.5 Latin America
7.5.1 Market size, by country, 2017 - 2028 (USD Million)
7.5.2 Market size, by product, 2017 - 2028 (USD Million)
7.5.3 Market size, by application, 2017 - 2028 (USD Million)
7.5.4 Market size, by end-use, 2017 - 2028 (USD Million)
7.5.5 Brazil
7.5.5.1 Market size, by product, 2017 - 2028 (USD Million)
7.5.5.2 Market size, by application, 2017 - 2028 (USD Million)
7.5.5.3 Market size, by end-use, 2017 - 2028 (USD Million)
7.5.6 Mexico
7.5.6.1 Market size, by product, 2017 - 2028 (USD Million)
7.5.6.2 Market size, by application, 2017 - 2028 (USD Million)
7.5.6.3 Market size, by end-use, 2017 - 2028 (USD Million)
7.5.7 Argentina
7.5.7.1 Market size, by product, 2017 - 2028 (USD Million)
7.5.7.2 Market size, by application, 2017 - 2028 (USD Million)
7.5.7.3 Market size, by end-use, 2017 - 2028 (USD Million)
7.6 MEA
7.6.1 Market size, by country, 2017 - 2028 (USD Million)
7.6.2 Market size, by product, 2017 - 2028 (USD Million)
7.6.3 Market size, by application, 2017 - 2028 (USD Million)
7.6.4 Market size, by end-use, 2017 - 2028 (USD Million)
7.6.5 South Africa
7.6.5.1 Market size, by product, 2017 - 2028 (USD Million)
7.6.5.2 Market size, by application, 2017 - 2028 (USD Million)
7.6.5.3 Market size, by end-use, 2017 - 2028 (USD Million)
7.6.6 Saudi Arabia
7.6.6.1 Market size, by product, 2017 - 2028 (USD Million)
7.6.6.2 Market size, by application, 2017 - 2028 (USD Million)
7.6.6.3 Market size, by end-use, 2017 - 2028 (USD Million)
7.6.7 UAE
7.6.7.1 Market size, by product, 2017 - 2028 (USD Million)
7.6.7.2 Market size, by application, 2017 - 2028 (USD Million)
7.6.7.3 Market size, by end-use, 2017 - 2028 (USD Million)
Chapter 8 Company Profiles
8.1 Competitive dashboard, 2021
8.2 FCI Ophthalmic
8.2.1 Business overview
8.2.2 Financial data
8.2.3 Product landscape
8.2.4 Strategic outlook
8.2.5 SWOT analysis
8.3 Medennium
8.3.1 Business overview
8.3.2 Financial data
8.3.3 Product landscape
8.3.4 Strategic outlook
8.3.5 SWOT analysis
8.4 BVI
8.4.1 Business overview
8.4.2 Financial data
8.4.3 Product landscape
8.4.4 Strategic outlook
8.4.5 SWOT analysis
8.5 Lacrimedics Inc
8.5.1 Business overview
8.5.2 Financial data
8.5.3 Product landscape
8.5.4 Strategic outlook
8.5.5 SWOT analysis
8.6 Rumex International Co
8.6.1 Business overview
8.6.2 Financial data
8.6.3 Product landscape
8.6.4 Strategic outlook
8.6.5 SWOT analysis
8.7 Bess Medical Technology GmbH
8.7.1 Business overview
8.7.2 Financial data
8.7.3 Product landscape
8.7.4 Strategic outlook
8.7.5 SWOT analysis
8.8 Kaneka Corporation
8.8.1 Business overview
8.8.2 Financial data
8.8.3 Product landscape
8.8.4 Strategic outlook
8.8.5 SWOT analysis
8.9 Braintree Scientific
8.9.1 Business overview
8.9.2 Financial data
8.9.3 Product landscape
8.9.4 Strategic outlook
8.9.5 SWOT analysis
8.10 JEDMED
8.10.1 Business overview
8.10.2 Financial data
8.10.3 Product landscape
8.10.4 Strategic outlook
8.10.5 SWOT analysis
8.11 Walsh Medical Devices Inc
8.11.1 Business overview
8.11.2 Financial data
8.11.3 Product landscape
8.11.4 Strategic outlook
8.11.5 SWOT analysis
